TARDBP and amyotrophic lateral sclerosis: Indeed, a peptide that specifically inhibits mitochondrial TDP-43 addressing without affecting the localization and molecular functions of nuclear or cytoplasmic TDP-43 restores mitochondrial function, ameliorates neurodegenerative damage and enhances motor performance in several TDP-43-mutated mouse models of ALS [111].